Most weight loss achieved using injectable obesity drugs can be maintained by switching to orforglipron, study shows

Credit: Unsplash/CC0 Public Domain

New research presented at the European Congress on Obesity (ECO2026) in Istanbul, Turkey (12–15 May) and

Continue Reading


News Source: medicalxpress.com

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *